Aequus Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AQSZF research report →
Price Chart
About the company
Aequus Pharmaceuticals Inc. is a specialized pharmaceutical firm based in Vancouver, Canada, dedicated to the development and commercialization of medicinal products across the country. The company concentrates its efforts on several key medical disciplines, including neurological conditions, ophthalmology, and transplantation medicine.
- CEO
- Douglas Glen Janzen
- IPO
- 2015
- Employees
- 12
- HQ
- Vancouver, BC, CA
Get TickerSpark's AI analysis on AQSZF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $159.16K
- P/E
- -1.52
- PEG
- -0.01
- P/S
- 0.95
- P/B
- -0.10
- EV/EBITDA
- -32.38
- Div Yield
- 0.00%
- Gross Margin
- 53.98%
- Op Margin
- -38.34%
- Net Margin
- -62.96%
- ROE
- 6.18%
- ROIC
- 30.88%
Latest fiscal year · YoY change
- Revenue
- $584.24K+129.2%
- Gross Profit
- $332.30K+131.3%
- Op Income
- $-2,127,199
- Net Income
- $-2,177,662+26.5%
- EPS
- $-0.02+26.8%
- OCF Growth
- +27.8%
- FCF Growth
- +27.8%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.21
- RSI (14)
- 43
- Avg Volume
- 7.48K
No earnings-call transcripts are available for AQSZF yet.
- Free Float
- 85.3%
- Shares Outstanding
- 132.63M
- Float Shares
- 113.16M
Our AQSZF coverage
Recent articles, reports, and earnings notes.
No research on AQSZF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AQSZF report →Aequus Announces Completion of Previously Announced Sale of ZIMED(R) PF
thenewswire.com · Mar 31
Aequus Provides Additional Disclosure in Connection with Annual General and Special Meeting of Shareholders
thenewswire.com · Nov 13
Aequus Provides Additional Disclosure in Connection with Annual General and Special Meeting of Shareholders
thenewswire.com · Nov 12
Aequus Announces Giovanni Di Genova Joining Board of Directors
thenewswire.com · Sep 22
Aequus Reports First Quarter 2025 Financial Highlights
thenewswire.com · May 21
Aequus Reports Second Quarter 2023 Financial Highlights and General Update
globenewswire.com · Aug 29
Aequus Announces Zimed PF Now Available in Canada
globenewswire.com · Aug 24
Aequus Announces Zimed PF Website Launch
globenewswire.com · Aug 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.